ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients

Detalles Bibliográficos
Autores principales: Liu, Dingxie, Hao, Qiongyu, Li, Jieqing, Li, Qun, Wang, Kun, Geng, Qing, Wu, Yutong, Vadgama, Jaydutt V., Wu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257990/
https://www.ncbi.nlm.nih.gov/pubmed/35486908
http://dx.doi.org/10.1002/cac2.12296
_version_ 1784741443392241664
author Liu, Dingxie
Hao, Qiongyu
Li, Jieqing
Li, Qun
Wang, Kun
Geng, Qing
Wu, Yutong
Vadgama, Jaydutt V.
Wu, Yong
author_facet Liu, Dingxie
Hao, Qiongyu
Li, Jieqing
Li, Qun
Wang, Kun
Geng, Qing
Wu, Yutong
Vadgama, Jaydutt V.
Wu, Yong
author_sort Liu, Dingxie
collection PubMed
description
format Online
Article
Text
id pubmed-9257990
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92579902022-07-08 ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients Liu, Dingxie Hao, Qiongyu Li, Jieqing Li, Qun Wang, Kun Geng, Qing Wu, Yutong Vadgama, Jaydutt V. Wu, Yong Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2022-04-29 /pmc/articles/PMC9257990/ /pubmed/35486908 http://dx.doi.org/10.1002/cac2.12296 Text en © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Liu, Dingxie
Hao, Qiongyu
Li, Jieqing
Li, Qun
Wang, Kun
Geng, Qing
Wu, Yutong
Vadgama, Jaydutt V.
Wu, Yong
ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title_full ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title_fullStr ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title_full_unstemmed ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title_short ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title_sort zbed2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257990/
https://www.ncbi.nlm.nih.gov/pubmed/35486908
http://dx.doi.org/10.1002/cac2.12296
work_keys_str_mv AT liudingxie zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT haoqiongyu zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT lijieqing zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT liqun zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT wangkun zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT gengqing zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT wuyutong zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT vadgamajayduttv zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT wuyong zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients

Ejemplares similares